This article has Open Peer Review reports available.
Saussurea lappa extract suppresses TPA-induced cell invasion via inhibition of NF-κB-dependent MMP-9 expression in MCF-7 breast cancer cells
- Ha-Rim Kim†1, 10,
- Jeong-Mi Kim†1,
- Mi-Seong Kim1,
- Jin-Ki Hwang1,
- Yeon-Ju Park1,
- Sei-Hoon Yang2,
- Hye-Jung Kim3,
- Do-Gon Ryu4,
- Dong-Sung Lee5,
- Hyuncheol Oh5, 6, 7,
- Youn-Chul Kim5, 6, 7,
- Yun-Jin Rhee9,
- Byung-Soon Moon9,
- Jong-Min Yun9,
- Kang-Beom Kwon1, 4, 10Email author and
- Young-Rae Lee1, 8, 10Email author
© Kim et al.; licensee BioMed Central Ltd. 2014
Received: 12 December 2013
Accepted: 13 May 2014
Published: 25 May 2014
Saussurea lappa (SL) has been used as a traditional herbal medicine to treat abdominal pain and tenesmus, and has been suggested to possess various biological activities, including anti-tumor, anti-ulcer, anti-inflammatory, anti-viral, and cardiotonic activities. The effect of SL on breast cancer metastasis, however, is unknown. Cell migration and invasion are crucial in neoplastic metastasis. Matrix metalloproteinase-9 (MMP-9), which degrades the extracellular matrix, is a major component in cancer cell invasion.
Cell viability was examined by MTT assay, whereas cell motility was measured by invasion assay. Western blot, Real-time PCR, and Zymography assays were used to investigate the inhibitory effects of ESL on matrix metalloproteinase-9 (MMP-9) expression level in MCF-7 cells. EMSA confirmed the inhibitory effects of ESL on DNA binding of NF- κB in MCF-7 cells.
Cells threated with various concentrations of Saussurea lappa (ESL) for 24 h. Concentrations of 2 or 4 μM did not lead to a significant change in cell viability or morphology. Therefore, subsequent experiments utilized the optimal non-toxic concentration (2 or 4 μM) of ESL. In this study, we investigated the inhibitory effect of ethanol extract of ESL on MMP-9 expression and cell invasion in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MCF-7 cells. ESL inhibited the TPA-induced transcriptional activation of nuclear factor-kappa B (NF-κB). However, this result obtained that ESL did not block the TPA-induced phosphorylation of the kinases: p38, ERK, and JNK. Therefore, ELS-mediated inhibition of TPA-induced MMP-9 expression and cell invasion involves the suppression of NF-kB pathway in MCF-7 cells.
These results indicate that ELS-mediated inhibition of TPA-induced MMP-9 expression and cell invasion involves the suppression of NF-kB pathway in MCF-7 cells. Thus, ESL has potential for controlling breast cancer invasiveness in vitro.
Breast cancer is one of the leading causes of malignancy-related death in women. Most breast cancer deaths are caused by distant metastasis from the primary tumor site. Failure in its treatment mainly arises from cancer proliferation, invasion, and metastasis, which ultimately lead to the death of patients. Penetration of the extracellular basement membrane by cells is the premise of cancer cell metastasis, where a variety of proteases play essential roles. Invasion and metastasis are the fundamental properties and major causes of morbidity and mortality in breast cancer patients. Molecular mechanisms of cancer cell invasion and metastasis involve a complex series of events. One such early event involves proteolytic degradation of the components of the extracellular matrix (ECM), which provides biochemical and mechanical barriers to cell movement in cancer cells. The ECM consists of type IV collagen, laminin, heparan sulfate proteoglycan, nidogen, and fibronectin. ECM degradation requires extracellular proteinases, of which the matrix metalloproteinases (MMPs) have been shown to play a critical role in breast cancer.
MMPs are a major group of enzymes that regulate cellular matrix composition, and are zinc- and calcium-dependent endopeptidases. Based on their substrates, MMPs are classified into four subclasses including collagenases, gelatinases, and stromelysins. MMP-9 in particular is considered to be one of the critical MMPs involved in cancer invasion and has been found to be directly associated with the invasion, metastasis, and poor prognosis of breast cancer[5, 6]. Therefore, inhibiting MMP-9 expression and/or its upstream regulatory pathways might be critical in treating malignant tumors, including breast carcinoma. A variety of stimuli, including growth factors (e.g., fibroblast growth factor-2, epidermal growth factor, and hepatocyte growth factor), cytokines (e.g., tumor necrosis factor-alpha), oncogenes (e.g., Ras), and 12-O- tetradecanoylphorbol-13-acetate (TPA) are known to induce MMP-9 expression[7–11]. Among these stimuli, TPA is a well-known selective activator of protein kinase C (PKC) and can stimulate MMP-9 synthesis and secretion in breast cancer cell invasion[12, 13]. Cytokine and TPA treatments induce MMP-9 expression via activation of transcription factors such as nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1)[14–16], both of which have binding sites on the MMP-9 gene promoter. The NF-κB and AP-1 elements are centrally involved in MMP-9 gene induction by TPA[14, 15]. The mitogen-activated protein kinase (MAPK) signaling pathway is important for AP-1 activation, and NF-κB activation requires I-κB kinase, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), or p38 MAPK, depending on the cell type[11, 18, 19].
Saussurea lappa (SL) is indigenous to India and Pakistan and has been cultivated in Southwest China, where it is utilized as a medicine. The dried roots of S. lappa have been traditionally used to alleviate pain from abdominal distention and tenesmus, anorexia-associated indigestion, dysentery, nausea, and vomiting. Previous in vitro cell culture studies have shown that SL has anti-ulcer, anti-inflammatory, anti-viral, and anti-tumor properties[24, 25]. In addition, SL inhibits the growth of several types of cancer cells[20, 26, 27]. However, the mechanism by which SL mediates anti-invasiveness is not well understood. A recent study showed that SL inhibits the cytokine-induced activation of NF-κB, a transcription factor that is important in the regulation of MMP-9. Accordingly, it has been hypothesized that SL may have anti-metastasis properties based on findings of the inhibition of cell invasion by SL. In this study, we addressed this hypothesis by assessing the potential effects of SL on TPA-induced cell invasion and MMP-9 expression in MCF-7 human breast cancer cells with related molecular mechanisms. Our findings demonstrate that ethanol extract of SL (ESL) suppresses TPA-induced MMP-9 expression by blocking the NF-κB signaling pathways, and that the suppression of MMP-9 expression correlates with inhibited cell invasion.
Cells and materials
MCF-7 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics at 37°C in a 5% CO2 incubator. TPA, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and anti-β-actin antibody were obtained from Sigma-Aldrich (St. Louis, MO, USA). Antibodies against p38, phosphorylated p38 (p-p38), JNK, p-JNK, ERK, p-ERK, phosphorylated c-Jun (p-c-Jun), phosphorylated I-kappa-B-alpha (p-IκBα), and phosphorylated I-kappa B kinase-alpha (p-IKKα) were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies against MMP-9, p50, p65, IκBα, IKKα, IKKβ, PKCα, PKCδ, proliferating cell nuclear antigen (PCNA), and horseradish peroxidase (HRP)-conjugated IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Alpha 32phosphorous-labelled deoxycytidine triphosphate ([α-32P]dCTP) was obtained from Amersham (Buckinghamshire, UK). DMEM containing a high concentration of glucose, FBS, and phosphate-buffered saline (PBS), was obtained from Gibco-BRL (Gaithersburg, ME, USA).
Plant material and preparation of NNMBS19
The dried root of Saussurea lappa (Compositae) were purchased from the University Oriental Herbal Drugstore, Iksan, Korea, in August 2010, and a voucher specimen was deposited at the Herbarium of the College of Pharmacy at Wonkwang University, Iksan, Korea. The dried root of S. lappa (50 g) were extracted twice with hot 70% ethanol (1 L) for 2 h at room temperature, and filtered with filter paper. The filtrate was evaporated in vacuo to produce a 70% ethanol extract (10.58 g, 21.2 w/w%). The 70% ethanol extract was suspended in distilled water (100 mL), followed by filtration. The residue derived from the filtration was dissolved in hot ethanol and filtered again. The filtrate was then evaporated in vacuo to obtain a standardized fraction of S. lappa (NNMBS198, 1000.3 mg, 2.01 w/w%). NNMBS198 was deposited at the Standardized Material Bank for New Botanical Drugs, College of Pharmacy at Wonkwang University.
Determination of cell viability
The effect of ESL on MCF-7 cell viability was determined using an established MTT assay. In brief, 3 × l04 cells were seeded in wells and incubated at 37°C for 24 h to allow attachment. The attached cells were untreated or treated with 1, 2, 5, 10, or 30 μg/mL ESL for 24 h at 37°C. The cells were washed with PBS prior to adding MTT (0.5 mg/mL in PBS) and incubated at 37°C for 30 min. Formazan crystals were dissolved with dimethyl sulfoxide (100 μL/well) and detected at 570 nm using a Model 3550 Microplate Reader (Bio-Rad; Richmond, CA, USA).
Western blot analysis
MCF-7 cells (5 × 105) were pre-treated with ESL (2 or 4 μg/mL) for 1 h and then incubated with TPA for 24 h at 37°C. Cells were lysed with ice-cold M-PER® Mammalian Protein Extraction Reagent (Pierce Biotechnology; Rockford, IL, USA), and protein concentration was determined using the Bradford method. Samples (20 μg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with 10% acrylamide and transferred to Hybond™ polyvinylidene fluoride membranes (GE Healthcare Life Sciences; Buckinghamshire, UK) using a western blot apparatus. Each membrane was blocked for 2 h with 2% bovine serum albumin or 5% skim milk and then incubated overnight at 4°C with 1 μg/mL of a 1:2000 dilution of primary antibody. HRP-conjugated IgG (1:2000 dilution) was used as the secondary antibody. Protein expression levels were determined by signal analysis using an image analyzer (Fuji-Film; Tokyo, Japan).
Gelatin zymography assay
Conditioned media was collected after 24 h stimulation, mixed with non-reducing sample buffer, and electrophoresed on a polyacrylamide gel containing 0.1% (w/v) gelatin. The gel was washed at room temperature for 30 min with 2.5% (v/v) Triton X-100 solution, and subsequently incubated at 37°C for 16 h in 5 mM CaCl2, 0.02% (v/v) Brij, and 50 mM Tris–HCl (pH 7.5). The gel was stained for 30 min with 0.25% (w/v) Coomassie Brilliant Blue in 40% (v/v) methanol/7% (v/v) acetic acid and photographed on an image analyzer (Fuji-Film). Proteolysis was visualized as a white zone in a dark blue field. Densitometric analysis was performed using Multi Gauge Image Analysis software (Fuji-Film).
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted from cells using a FastPure™ RNA Kit (TaKaRa; Shiga, Japan). RNA concentration and purity were determined by absorbance at 260/280 nm. cDNA was synthesized from 1 μg total RNA using a PrimeScript™ RT reagent Kit (TaKaRa). MMP-9 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA expression levels were determined by real-time PCR using the ABI PRISM 7900 sequence detection system and SYBR® Green (Applied Biosystems; Foster City, CA, USA). The primers were the following: MMP-9 (NM 004994) sense: 5′-CCTGGAGACCTGAGAACCAATCT-3′, antisense: 5′-CCACCCGAGTGTAACCATAGC-3′; and GAPDH (NM 002046) sense: 5′-ATGGAAATCCCATCACCATCTT-3′, antisense: 5′-CGCCCCACTTGATTTTGG-3′. To control for variation in mRNA concentration, all results were normalized to the GAPDH housekeeping gene. Relative quantification was performed using the comparative ∆∆Ct method according to the manufacturer’s instructions.
Preparation of nuclear extract
MCF-7 cells (2 × 106) were treated with ESL in the presence or absence of TPA for 4 h. Cells were immediately washed twice, scraped into 1.5 mL of ice-cold PBS (pH 7.5), and pelleted at 1500 × g for 3 min. Cytoplasmic and nuclear extracts were prepared from cells using the NE-PER® Nuclear and Cytoplasmic Extraction Reagents (Pierce Biotechnology; Rockford, IL, USA).
Electrophoretic mobility shift assay (EMSA)
Activation of NF-κB and AP-1 was assessed by gel mobility shift assays using nuclear extracts. Oligonucleotides containing the κ-chain (κB, 5′-CCGGTTAACAGAGGGGGCTTTCCGAG-3′) or AP-1 (5′-CGCTTG ATGAGTCAGCCGGAA-3′) binding site were synthesized and used as probes for gel retardation assays. The two complementary strands were annealed and labeled with [α-32P]dCTP. Labeled oligonucleotides (10,000 cpm), 10 μg of nuclear extracts, and binding buffer (10 mM Tris–HCl, pH 7.6, 500 mM KCl, 10 mM EDTA, 50% [v/v] glycerol, 100 ng poly[deoxyinosinic-deoxycytidylic] acid [poly(dI · dC)], 1 mM dithiothreitol) were then incubated for 30 min at room temperature in a final volume of 20 μL. The reaction mixtures were analyzed by electrophoresis on 4% polyacrylamide gels in 0.5× Tris-borate buffer. The gels were dried and examined by autoradiography. Specific binding was controlled by competition with a 50-fold excess of cold κB oligonucleotide.
The invasion assay was carried out in 24-well chambers (8-μm pore size) coated with 20 μL Matrigel™ diluted in DMEM. The Matrigel™ coating was re-hydrated in 0.5 mL DMEM for 30 min immediately before the experiments. Cells (2 × 105) were seeded in the upper chambers of wells, and chemoattractant was placed in the bottom chambers. Conditioned medium (0.5 mL) was added to the lower compartment of the invasion chamber. The chambers were incubated for 24 h. Following incubation, cells on the upper side of the chamber were removed using cotton swabs, and cells that had migrated were fixed and stained with Toluidine blue solution. Invading cells were counted in five randomly selected areas of the membrane using a light microscope. Analyzed data represent the means ± standard error (SE) from three individual experiments each performed in triplicate.
Statistical data analysis was performed using ANOVA and Duncan’s test. Differences with p < 0.05 were considered statistically significant.
Effect of ESL on the viability of MCF-7 cells and MDA-MB-231 cells
Effect of ESL on TPA-induced MMP-9 expression in MCF-7 cells
Effect of ESL on the TPA-induced NF-κB and AP-1 DNA binding activity
MAPK signaling pathways are not involved in the inhibition of TPA-induced MMP-9 expression and secretion by ESL
The findings of this study provide the first evidence that ESL inhibits the TPA-induced expression of MMP-9 in MCF-7 breast cancer cells. Furthermore, we show the molecular mechanism of this inhibition to be a disruption of TPA-mediated activation of the NF-κB pathway, a finding in agreement with previous research, which has demonstrated that NF-κB is molecular target in ESL treated cells.
Breast cancer remains one of the most threatening mortality factors in women throughout the world despite the significant advancements in its early detection techniques and relevant therapeutic approaches. With a current mortality rate of 40%, over one million women worldwide will fall victim to breast cancer. Metastasis is the primary cause of breast cancer mortality. Tumor metastasis is a complex, multistep process that includes cell proliferation, ECM degradation, cell migration, and tumor growth at metastatic sites. Morphologically, tumor invasion is associated with the presence of a distorted edge of the primary tumor, where individual or cohorts of tumor cells actively invade the tissue ECM surrounding the primary tumor. MMP-9 is important for tumor metastasis because of its role in basement membrane cleavage, which allows migratory phenotype cells to be more invasive and motile[32–34]. In previous reports, inflammatory cytokines, growth factors, and phorbol esters were shown to stimulate MMP-9 by activating different intracellular signaling pathways in breast cancer cells[35–37]. The inhibition of MMP-9 expression might therefore be important in the development of a therapies for tumor metastasis.
To understand the TPA-induced signaling cascade underlying MMP-9 expression in MCF-7 cells, we assessed the effects of ESL on three MAPKs and the DNA binding abilities of transcription factors. The three major MAPK families, JNK, ERK, and p38 kinase, are expressed in MCF-7 cells, and their active phosphorylated forms can be detected. MAPK signaling pathways are important for NF-κB and AP-1 activation, which require IκB kinase, PI3K-Akt, or p38 MAPK, depending on the cell type[11, 19, 38]. In addition, it has been established that TPA induces the nuclear transcription factors NF-κB and AP-1 in MCF-7 cells. NF-κB and AP-1 are important in regulating MMP-9, as the MMP-9 gene promoter contains NF-κB and AP-1 binding sites. The NF-κB and AP-1 elements are centrally involved in TPA-mediated MMP-9 gene induction[15, 29]. Our results, however, show that ESL inhibits the activation of NF-κB but not of MAPK or AP-1 in MCF-7 cells. This suggests that ESL inhibits TPA-induced MMP-9 expression via the NF-κB pathway.Our findings confirm that TPA-stimulated cell invasion is suppressed by ESL as demonstrated by the Matrigel™ invasion assay showing inhibition of the TPA-induced invasion potential of MCF-7 cells by ESL (Figure 6).
Our results demonstrated that ESL is a potent inhibitor of TPA-induced MMP-9 expression and strongly blocks the action of the NF-κB signaling pathway in MCF-7 cells. This is the first report demonstrating the suppression of TPA-stimulated cancer cell invasion by inhibition of MMP-9 expression via suppression of NF-κB pathways in MCF-7 cells.
This work was supported by the National Research Foundation of Korea [NRF] grant funded by the Korea government [MEST] [No. 2011–0030130].
- Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin. 2005, 55 (1): 10-30.View ArticlePubMedGoogle Scholar
- Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997, 89 (17): 1260-1270.View ArticlePubMedGoogle Scholar
- Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991, 5 (8): 2145-2154.PubMedGoogle Scholar
- Nakajima M, Welch DR, Belloni PN, Nicolson GL: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 1987, 47 (18): 4869-4876.PubMedGoogle Scholar
- Itoh Y, Nagase H: Matrix metalloproteinases in cancer. Essays Biochem. 2002, 38: 21-36.View ArticlePubMedGoogle Scholar
- Brinckerhoff CE, Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002, 3 (3): 207-214.View ArticlePubMedGoogle Scholar
- Gum R, Wang H, Lengyel E, Juarez J, Boyd D: Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene. 1997, 14 (12): 1481-1493.View ArticlePubMedGoogle Scholar
- Newton AC: Regulation of protein kinase C. Curr Opin Cell Biol. 1997, 9 (2): 161-167.View ArticlePubMedGoogle Scholar
- Zeigler ME, Chi Y, Schmidt T, Varani J: Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol. 1999, 180 (2): 271-284.View ArticlePubMedGoogle Scholar
- Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M: Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol. 2001, 281 (6): L1444-L1452.PubMedGoogle Scholar
- Weng CJ, Chau CF, Hsieh YS, Yang SF, Yen GC: Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis. 2008, 29 (1): 147-156.View ArticlePubMedGoogle Scholar
- Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM, Chen YC: Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis. 2008, 29 (9): 1807-1815.View ArticlePubMedGoogle Scholar
- Lee SO, Jeong YJ, Kim M, Kim CH, Lee IS: Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem Biophys Res Commun. 2008, 366 (4): 1019-1024.View ArticlePubMedGoogle Scholar
- Oh JH, Chung AS, Steinbrenner H, Sies H, Brenneisen P: Thioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts. Arch Biochem Biophys. 2004, 423 (1): 218-226.View ArticlePubMedGoogle Scholar
- Hong S, Park KK, Magae J, Ando K, Lee TS, Kwon TK, Kwak JY, Kim CH, Chang YC: Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J Biol Chem. 2005, 280 (26): 25202-25209.View ArticlePubMedGoogle Scholar
- Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH, Kim WK, Kim HS: Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun. 2005, 335 (4): 1017-1025.View ArticlePubMedGoogle Scholar
- Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J: Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol. 2000, 165 (10): 5788-5797.View ArticlePubMedGoogle Scholar
- Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995, 270 (28): 16483-16486.View ArticlePubMedGoogle Scholar
- Madrid LV, Mayo MW, Reuther JY, Baldwin AS: Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem. 2001, 276 (22): 18934-18940.View ArticlePubMedGoogle Scholar
- Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T: Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003, 253 (1–2): 269-285.View ArticlePubMedGoogle Scholar
- Yoshikawa M, Hatakeyama S, Inoue Y, Yamahara J: Saussureamines A, B, C, D, and E, new anti-ulcer principles from Chinese Saussureae Radix. Chem Pharm Bull (Tokyo). 1993, 41 (1): 214-216.View ArticleGoogle Scholar
- Lim JY, Shin CS, Chung EJ, Kim JS, Kim HU, Oh SJ, Choi WB, Ryou CS, Kim JB, Kwon MS, Chung TY, Song SI, Kim JK, Nahm BH, Hwang YS, Eun MY, Lee JS, Cheong JJ, Choi YD: Analysis of expressed sequence tags from Brassica rapa L. ssp. pekinensis. Mol Cells. 2000, 10 (4): 399-404.PubMedGoogle Scholar
- Chen HC, Chou CK, Lee SD, Wang JC, Yeh SF: Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antivir Res. 1995, 27 (1–2): 99-109.View ArticlePubMedGoogle Scholar
- Tuoheti Y, Itoi E, Minagawa H, Wakabayashi I, Kobayashi M, Okada K, Shimada Y: Quantitative assessment of thinning of the subscapularis tendon in recurrent anterior dislocation of the shoulder by use of magnetic resonance imaging. J Shoulder Elbow Surg. 2005, 14 (1): 11-15.View ArticlePubMedGoogle Scholar
- Ko SG, Koh SH, Jun CY, Nam CG, Bae HS, Shin MK: Induction of apoptosis by Saussurea lappa and Pharbitis nil on AGS gastric cancer cells. Biol Pharm Bull. 2004, 27 (10): 1604-1610.View ArticlePubMedGoogle Scholar
- Cho JY, Kim AR, Jung JH, Chun T, Rhee MH, Yoo ES: Cytotoxic and pro-apoptotic activities of cynaropicrin, a sesquiterpene lactone, on the viability of leukocyte cancer cell lines. Eur J Pharmacol. 2004, 492 (2–3): 85-94.View ArticlePubMedGoogle Scholar
- Oh GS, Pae HO, Chung HT, Kwon JW, Lee JH, Kwon TO, Kwon SY, Chon BH, Yun YG: Dehydrocostus lactone enhances tumor necrosis factor-alpha-induced apoptosis of human leukemia HL-60 cells. Immunopharmacol Immunotoxicol. 2004, 26 (2): 163-175.View ArticlePubMedGoogle Scholar
- Choi YK, Cho SG, Woo SM, Yun YJ, Jo J, Kim W, Shin YC, Ko SG: Saussurea lappa Clarke-Derived Costunolide Prevents TNF alpha -Induced Breast Cancer Cell Migration and Invasion by Inhibiting NF- kappa B Activity. Evid Based Complement Altern Med: eCAM. 2013, 2013: 936257-Google Scholar
- Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, Kim SH, Kim JG, Kim CH: Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 2004, 18 (14): 1670-1681.View ArticlePubMedGoogle Scholar
- Stetler-Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol. 1996, 7 (3): 147-154.View ArticlePubMedGoogle Scholar
- Deryugina EI, Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25 (1): 9-34.View ArticlePubMedGoogle Scholar
- Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000, 10 (6): 415-433.View ArticlePubMedGoogle Scholar
- Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2 (3): 161-174.View ArticlePubMedGoogle Scholar
- Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M: Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer. 2001, 84 (11): 1488-1496.View ArticlePubMedPubMed CentralGoogle Scholar
- Cho HJ, Kang JH, Kwak JY, Lee TS, Lee IS, Park NG, Nakajima H, Magae J, Chang YC: Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis. 2007, 28 (5): 1104-1110.View ArticlePubMedGoogle Scholar
- Kajanne R, Miettinen P, Mehlem A, Leivonen SK, Birrer M, Foschi M, Kahari VM, Leppa S: EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol. 2007, 212 (2): 489-497.View ArticlePubMedGoogle Scholar
- Srivastava AK, Qin X, Wedhas N, Arnush M, Linkhart TA, Chadwick RB, Kumar A: Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J Biol Chem. 2007, 282 (48): 35113-35124.View ArticlePubMedPubMed CentralGoogle Scholar
- Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D: Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene. 2001, 20 (56): 8066-8074.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/170/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.